CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Reports

We found 6971 result(s)

Long-Acting Beta2-Agonist and Inhaled Corticosteroid Combination Therapy for Adult Persistent Asthma: Systematic Review of Clinical Outcomes and Economic Evaluation

Last Updated: September 5, 2010
Result type: Reports

[Adapted from Bond K, Coyle D, O'Gorman K, Coyle K, Spooner C, Lemière C, Vandermeer B, Tjosvold L, Rowe BH. Long-Acting Beta2-Agonist and Inhaled Corticosteroid Combination Therapy for Adult Persistent Asthma: Systematic Review of Clinical Outcomes and Economic Evaluation. [Technology report; no.122]. Ottawa: Canadian Agency for Drugs and Techn...

Overview of Short-Acting Agents for Procedural Sedation and Analgesia in Canadian Emergency Departments

Last Updated: May 5, 2008
Result type: Reports

Technology Short-acting agents for procedural sedation and analgesia (PSAs) propofol, ketamine HCl, etomidate, and ketamine combined with low-dose propofol (ketofol). Condition Adults who present to emergency departments (EDs) for painful procedures (i.e., treatment for bone fractures, major joint dislocations, cardioversion, and other proced...

An Economic Analysis of Sumatriptan for Acute Migraine

Last Updated: January 1, 1997
Result type: Reports

Cite as: Ilersich L. An economic analysis of sumatriptan for acute migraine. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1997. Background Migraine is an episodic headache that may be either a steady or throbbing pain. Episodes of migraine can vary in intensity, frequency and duration, and are often accompani...

Pharmaceutical management of peptic ulcer disease

Last Updated: January 1, 1996
Result type: Reports

Cite as: Perras C, Otten N. Pharmaceutical management of peptic ulcer disease. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1996. Summary Remarks Approximately 10% of the adult population will suffer from peptic ulcer disease (PUD) at some point in their life. Most individuals experiencing heartburn after eat...

COVID-19 Update

Published on: April 6, 2020
Result type: General Content

CADTH continues to support health care decision-makers throughout this challenging period. We have successfully shifted to a virtual office and have the tools in place to continue delivering our programs and services. Further, we continue to monitor our operations to identify potential disruptions to our core business activities and we will prom...

Bisphosphonates for the primary and secondary prevention of osteoporotic fractures in postmenopausal women: a meta-analysis

Last Updated: November 2, 2006
Result type: Reports

Technology Bisphosphonate drugs to prevent osteoporotic fractures: etidronate, alendronate, and risedronate. Condition Osteoporosis is a skeletal disorder characterized by compromised bone strength predisposing a person to increased risk of fracture. In Canada, approximately one in four women has osteoporosis. Issue The incidence of osteopo...

Triptans for Acute Migraine: Comparative Clinical Effectiveness and Cost-effectiveness

Last Updated: March 12, 2007
Result type: Reports

Technology and Condition Serotonin receptor (5HT1) agonists (triptans):almotriptan, eletriptan, naratriptan, sumatriptan succinate/hemisulfate, rizatriptan, and zolmitriptan fortreatment of acute migraine in adults and adolescents Issue Acute migraine is associated with significant costs to public payers and society. The use of triptan therap...

Long-acting ß2-agonists (LABA) plus Corticosteroids versus LABA Alone for Chronic Obstructive Pulmonary Disease

Last Updated: March 27, 2007
Result type: Reports

Technology and Condition Combination therapy (CT) of an inhaled long-acting ß2-agonist (LABA) with an inhaled corticosteroid (ICS) in patients diagnosed with chronic obstructive pulmonary disease (COPD). Issue COPD affects at least 3.2% of the adult population and leads to significant associated health care costs. CT has been recommended in c...

Overview of Clinical and Cost-Effectiveness of Prostaglandin Analogues for Ophthalmic Use

Last Updated: June 26, 2007
Result type: Reports

Technology and Condition Prostaglandin analogues (PGAs) in the treatment of elevated intraocular pressure (IOP): bimatoprost, latanoprost, and travoprost Issue PGAs are more costly than alternative agents for the lowering of IOP. One policy decision to be made is whether reimbursement of these agents as first-line therapy with no restrictions...

Health Technology Expert Review Panel

Published on: February 11, 2019
Result type: General Content

The Health Technology Expert Review Panel (HTERP) is an advisory body to CADTH, convened to develop guidance and/or recommendations on non-drug health technologies to inform a range of stakeholders within the Canadian health care system. The HTERP approach is evidence-based and uses a multi-criteria framework that considers the strength and qua...